Top in cardiology: EPA monotherapy, ambulatory BP
Click Here to Manage Email Alerts
A new meta-analysis discussed how eicosapentaenoic acid monotherapy, compared with eicosapentaenoic acid plus docosahexaenoic acid, provided the greatest reduction in cardiovascular risk.
The report was the top story cardiology in last week.
Photo source: Adobe Stock
Another top story was a study whose authors concluded ambulatory BP readings are the best method of predicting stroke in older adults.
Read these and more top stories in cardiology below:
In omega-3 fatty acid trials, EPA alone yields greater CV risk reduction vs. EPA plus DHA
In a meta-analysis of omega-3 fatty acid trials, eicosapentaenoic acid monotherapy yielded the greatest reduction in CV risk vs. a combination of eicosapentaenoic acid and docosahexaenoic acid. Read more.
Ambulatory BP readings may provide best stroke prediction in older adults
Among older adults, all measures of ambulatory BP were associated with risk for stroke while office diastolic BP was only weakly associated, and central BP measures were not associated with stroke at all, researchers reported. Read more.
Women more likely than men to experience CV effects of sleep loss
Sleep loss caused a significant increase in 24-hour and sleep-time BP among healthy young adults, particularly women, according to data published in Hypertension. Read more.
FDA requests removal of strongest warning against statin use among pregnant women
The FDA requested removal of its contraindication against using cholesterol-lowering statin medicines among pregnant patients; however, most patients should stop statins once they learn they are pregnant. Read more.
AHA offers tips to prevent cardiac, other hazards during heat waves
There are five ways in which Americans can prevent heart-related and other adverse events from extreme heat, the American Heart Association stated in a press release. Read more.